These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 18685119)

  • 21. [Treatment of acromegaly with octreotide, a synthetic analog of somatostatin with extended action].
    Arosio M; Bazzoni N; Faglia G
    Minerva Endocrinol; 1990; 15(1):29-36. PubMed ID: 2274011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial.
    Petersenn S; Schopohl J; Barkan A; Mohideen P; Colao A; Abs R; Buchelt A; Ho YY; Hu K; Farrall AJ; Melmed S; Biller BM;
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2781-9. PubMed ID: 20410233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
    Bevan JS; Atkin SL; Atkinson AB; Bouloux PM; Hanna F; Harris PE; James RA; McConnell M; Roberts GA; Scanlon MF; Stewart PM; Teasdale E; Turner HE; Wass JA; Wardlaw JM
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4554-63. PubMed ID: 12364434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of combined octreotide and cabergoline treatment in patients with acromegaly: a retrospective clinical study and review of the literature.
    Suda K; Inoshita N; Iguchi G; Fukuoka H; Takahashi M; Nishizawa H; Yamamoto M; Yamada S; Takahashi Y
    Endocr J; 2013; 60(4):507-15. PubMed ID: 23291436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale of pre-surgical medical treatment with somatostatin analogs in acromegaly.
    Cappabianca P; Cavallo LM; Esposito F; Romano I; Colao A; de Divitiis E
    J Endocrinol Invest; 2003; 26(8 Suppl):55-8. PubMed ID: 15233214
    [No Abstract]   [Full Text] [Related]  

  • 26. [A new therapy for acromegaly].
    Beckers A; Stevenaert A; Hennen G
    Rev Med Liege; 1988 Jun; 43(11):429-32. PubMed ID: 2899902
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary medical therapy for acromegaly.
    Freda PU; Wardlaw SL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3031-3. PubMed ID: 9745396
    [No Abstract]   [Full Text] [Related]  

  • 28. Expert consensus document: A consensus on the medical treatment of acromegaly.
    Giustina A; Chanson P; Kleinberg D; Bronstein MD; Clemmons DR; Klibanski A; van der Lely AJ; Strasburger CJ; Lamberts SW; Ho KK; Casanueva FF; Melmed S;
    Nat Rev Endocrinol; 2014 Apr; 10(4):243-8. PubMed ID: 24566817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acromegaly; diagnosis and treatment].
    van der Lely AJ; de Herder WW; Hofland LJ; Lamberts SW
    Ned Tijdschr Geneeskd; 1996 Jul; 140(28):1436-40. PubMed ID: 8766766
    [No Abstract]   [Full Text] [Related]  

  • 30. [Octreotide, a somatostatin analogue].
    Luton JP
    Presse Med; 1994 Apr; 23(15):718. PubMed ID: 7521053
    [No Abstract]   [Full Text] [Related]  

  • 31. The development of dependence to an octapeptide somatostatin analog: contribution to the study of somatostatin analgesia.
    Paunović VR; Popović V
    Biol Psychiatry; 1989 May; 26(1):97-101. PubMed ID: 2541810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptomatic Chiari-I malformation in a patient with acromegaly.
    Lemar HJ; Perloff JJ; Merenich JA
    South Med J; 1994 Feb; 87(2):284-5. PubMed ID: 8115904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acromegaly. Proceedings of the Symposium on Somatostatin Analogues--Peptide Therapy in Action. January 9th, 1989, London.
    Horm Res; 1990; 33 Suppl 1():1-36. PubMed ID: 2358293
    [No Abstract]   [Full Text] [Related]  

  • 34. Commentary: The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study.
    Yanagihara TK; Wang TJC
    Neurosurgery; 2020 Sep; 87(3):E303-E304. PubMed ID: 32365186
    [No Abstract]   [Full Text] [Related]  

  • 35. Commentary: The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study.
    Régis J; Tuleasca C; Hopewell JW; Castinetti F
    Neurosurgery; 2020 Sep; 87(3):E301-E302. PubMed ID: 32348481
    [No Abstract]   [Full Text] [Related]  

  • 36. [Surgical treatment of acromegaly].
    HAMBERGER CA; HAMMER G; NORLEN G; SJOGREN B
    Nord Med; 1959 Sep; 62():1328-34. PubMed ID: 14399204
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of pre-operative somatostatin analogue therapy on treatment cost and remission in acromegaly.
    Polat Korkmaz O; Gurcan M; Nuhoglu Kantarci FE; Haliloglu O; Ozkaya HM; Sahin S; Oren MM; Tanriover N; Gazioglu N; Kadioglu P
    Pituitary; 2019 Aug; 22(4):387-396. PubMed ID: 31098838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pros and cons in endocrine practice: pre-surgical treatment with somatostatin analogues in acromegaly.
    Losa M; Bollerslev J
    Endocrine; 2016 Jun; 52(3):451-7. PubMed ID: 26785848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Place of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysis.
    Pita-Gutierrez F; Pertega-Diaz S; Pita-Fernandez S; Pena L; Lugo G; Sangiao-Alvarellos S; Cordido F
    PLoS One; 2013; 8(4):e61523. PubMed ID: 23634209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-surgical treatment with somatostatin analogues in patients with acromegaly: the case against.
    Losa M; Crippa VG
    J Endocrinol Invest; 2012 Jun; 35(6):616-8. PubMed ID: 22776974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.